A randomized phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma
CANCER, cilt.83, sa.12, ss.2475-2480, 1998 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 83 Sayı: 12
- Basım Tarihi: 1998
- Dergi Adı: CANCER
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.2475-2480
- Anahtar Kelimeler: advanced gastric carcinoma, cisplatin, epirubicin, etoposide, 5-fluorouracil, randomized controlled trial, CANCER, DOXORUBICIN, COMBINATION, FLUOROURACIL, CHEMOTHERAPY, ADRIAMYCIN, MITOMYCIN, REGIMENS, CELLS
- Ankara Üniversitesi Adresli: Evet
Özet
BACKGROUND, Gastric carcinoma is a substantial health problem in Turkey, and the majority of patients present with inoperable disease. The aim of this randomized trial was to assess the activity of 5-fluorouracil versus etoposide when combined with epirubicin plus cisplatin in patients with advanced gastric carcinoma (AGC)